Skip to content

A clinical study of a mouth rinse as a potential aid in improving overall gum health.

Prospective, open label, double arm, multi centre, comparative clinical Study on mouth rinse containing Chlorhexidine plus Hyaluronic Acid as a potential aid in improving overall gum health in patients post oral surgical procedures.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/06/054218
Enrollment
50
Registered
2023-06-20
Start date
Unknown
Completion date
Unknown
Last updated
2024-01-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: Mouth Rinse containing Chlorhexidine & Hyaluronic Acid: 10 ml of product twice daily (morning & evening) for the duration of 15 days Control Intervention1: Placebo (i.e., Saline): 10 ml

Sponsors

Dr. Reddys Laboratories Ltd.
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1) Males and Non-pregnant (self-declared)/Non-Lactating female subjects of age 18 to 50 years (both inclusive) at the time of consent. 2) Subjects who have undergone oral surgical procedure like tooth extraction, implant surgeries and periodontal surgeries. 3) Subjects willing to provide written informed consent for participating in the study. 4) Subject willing and able to follow the study protocol to participate in the study.

Exclusion criteria

Exclusion criteria: 1) Pregnant or breastfeeding or planning pregnancy during the study period. 2) Subjects receiving steroid medications, which would compromise the study. 3) Subjects having history of diabetes mellitus, acute cardiac and circulatory diseases, HIV, hepatitis. 4) Subjects with known allergy or sensitivity to Chlorhexidine and Hyaluronic Acid. 5) Subjects having problems of hemostasis and coagulation. 6) Subjects who consume alcohol. 7) Subjects smoking cigarette or consume any other form of tobacco. 8) Participation in a similar clinical study within the previous 30 Days. 9) Any other condition which could warrant exclusion from the study, as per the investigator’s discretion.

Design outcomes

Primary

MeasureTime frame
1) Assessment of wound healing using Healing index scale (versus baseline & placebo). 2) Assessment of wound healing using Percentage healing index (PHI) (only for subjects who have undergone tooth extraction) (versus baseline & placebo).Timepoint: Day 01 (before product administration), Day 03, Day 07, Day 15

Secondary

MeasureTime frame
1) Assessment of overall gum health by dental examination (versus baseline & placebo)Timepoint: Day 01 (before product administration), Day 03, Day 07, Day 15;2) Assessment of Subject Satisfaction Questionnaire after product administration.Timepoint: Day 03, Day 07, Day 15;3) Assessment of Product Response Index (Perception about Product) after product administration.Timepoint: Day 15

Countries

India

Contacts

Public ContactDr Rahul Rathod

Dr. Reddy’s Laboratories Ltd.

kirtishukla@drreddys.com9869770290

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026